Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B-and T-cell lymphomas

Clinical Nuclear Medicine

Volumn 35, Issue 8, 2010, Pages 571-575

  Chan, Winnie K S ^a   Au, Wing Yan ^a   Wong, Ching Yee O ^b   Liang, Raymond ^a   Leung, Anskar Y H ^a   Kwong, Yok Lam ^a   Khong, Pek Lan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

NK cell lymphoma; non Hodgkin lymphoma; PET CT; SUVmax

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; T CELL LYMPHOMA; ADOLESCENT; CHILD; COMPARATIVE STUDY; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FLUORODEOXYGLUCOSE F18; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77955146825     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181e4dcbf     Document Type: Article

References (13)

1. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16:206-214.
2. Schöder H, Noy A, Gönen M, et al. Intensity of 18Fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005;23:4643-4651.
3. Tang B, Malysz J, Douglas-Nikitin V, et al. Correlating metabolic activity with cellular proliferation in follicular lymphomas. Mol Imaging Biol. 2009; 11:296-302.
4. Brepoels L, Stroobants S, Vandenberghe P, et al. Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy. J Nucl Med. 2007;48: 390-397.
5. Khong PL, Pang CB, Liang R, et al. Fluorine-18 flurodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol. 2008;87:613-621.
6. Kwong YL, Chan AC, Liang RH. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol. 1997;15:71-79.
7. Li T, Zhang B, Ye Y, et al. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas. Hum Pathol. 2006;37:54-60.
8. Ngeow JY, Quek RH, Ng DC, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol. 2009;20:1543-1547.
9. Tsukamoto N, Kojima M, Hasegawa M, et al. The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-PET with 67Gallium scintigraphy in the evaluation of lymphoma relation to histologic subtypes based on the World Health Organization Classification. Cancer. 2007;110:652-659.
10. Suh C, Kang YK, Roh JL, et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. J Nucl Med. 2008;49:1783-1789.
11. Karantanis D, Subramaniam RM, Peller PJ, et al. The value of F-18Fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma. 2008;8:94-99.
12. Kako S, Izutsu K, Ota Y, et al. FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol. 2007;18:1685-1690.
13. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal NK/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2009;113: 3931-3937.